Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner
- PMID: 11743999
- DOI: 10.1016/s0006-8993(01)03228-0
Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner
Abstract
Several functional differences have been reported among the three human e2, e3, and e4 alleles of apolipoprotein E (apoE). One functional difference lies in the antioxidant potential of these alleles; e4 has the poorest potential. Interestingly, e4 also correlates with increased oxidative damage in the Alzheimer's disease (AD) brain, which may explain why the inheritance of the e4 allele is a risk factor for the onset of AD. Beta-amyloid (Abeta) is also intimately involved in AD and promotes oxidative damage in vitro; therefore, we have examined the role of the different apoE alleles in modulating Abeta(1-42)-induced oxidation to synaptosomes. Measurement of specific markers of oxidation in synaptosomes isolated from mice that express one of the human apoE alleles indicates that Abeta-induced increases of these markers can be modulated by apoE in an allele-dependent manner (e2>e3>e4). Increases in reactive oxygen species formation and protein and lipid oxidation were always greatest in e4 synaptosomes as compared to e2 and e3 synaptosomes. Our data support the role of apoE as a modulator of Abeta toxicity and, consistent with the antioxidant potentials of the three alleles, suggest that the e4 allele may not be as effective in this role as the e2 or e3 alleles of apoE. These results are discussed with reference to mechanistic implications for neurodegeneration in the AD brain.
Similar articles
-
Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.Free Radic Res. 2002 Dec;36(12):1307-13. doi: 10.1080/1071576021000049890. Free Radic Res. 2002. PMID: 12607822 Review.
-
Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease.Biochemistry. 2001 Feb 27;40(8):2548-54. doi: 10.1021/bi002312k. Biochemistry. 2001. PMID: 11327877
-
Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.Neurobiol Aging. 2002 Sep-Oct;23(5):655-64. doi: 10.1016/s0197-4580(01)00340-2. Neurobiol Aging. 2002. PMID: 12392766 Review.
-
Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.Neurobiol Dis. 2020 May;138:104795. doi: 10.1016/j.nbd.2020.104795. Epub 2020 Feb 6. Neurobiol Dis. 2020. PMID: 32036033 Free PMC article. Review.
-
Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes.J Neurosci Res. 2004 Aug 15;77(4):532-9. doi: 10.1002/jnr.20182. J Neurosci Res. 2004. PMID: 15264223
Cited by
-
Association of oxidative stress and inflammatory metabolites with Alzheimer's disease cerebrospinal fluid biomarkers in mild cognitive impairment.Alzheimers Res Ther. 2024 Jul 30;16(1):171. doi: 10.1186/s13195-024-01542-4. Alzheimers Res Ther. 2024. PMID: 39080778 Free PMC article.
-
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022. Physiol Rev. 2024. PMID: 37843394 Review.
-
Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches.Cell Mol Neurobiol. 2023 Oct;43(7):3115-3136. doi: 10.1007/s10571-023-01365-1. Epub 2023 May 25. Cell Mol Neurobiol. 2023. PMID: 37227619 Free PMC article. Review.
-
Uncovering mechanisms of brain inflammation in Alzheimer's disease with APOE4: Application of single cell-type lipidomics.Ann N Y Acad Sci. 2022 Dec;1518(1):84-105. doi: 10.1111/nyas.14907. Epub 2022 Oct 6. Ann N Y Acad Sci. 2022. PMID: 36200578 Free PMC article. Review.
-
Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.Mol Neurobiol. 2022 Jan;59(1):657-680. doi: 10.1007/s12035-021-02617-1. Epub 2021 Nov 9. Mol Neurobiol. 2022. PMID: 34751889 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
